JAMA Network
About The Study: This cohort study describes respiratory syncytial virus (RSV)-associated lower respiratory tract infection hospitalizations among infants in France who received both maternal RSVpreF vaccination and nirsevimab during the 2024-2025 RSV season.
/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.
